TY - JOUR
T1 - Synthesis and characterization of ruthenium compounds incorporating keto-amine ligands. The applications of catalytic transfer hydrogenation and cancer cell inhibition
AU - Lin, Tzung Han
AU - Das, Kuheli
AU - Datta, Amitabha
AU - Leu, Wohn Jenn
AU - Hsiao, Hung Chang
AU - Lin, Chia Her
AU - Guh, Jih Hwa
AU - Huang, Jui Hsien
N1 - Funding Information:
The authors express their appreciation to the Ministry of Science and Technology, Taiwan for financial assistance ( NSC 102-2738-M-018-001 ). We also thank the National Changhua University of Education for supporting the facility of X-ray diffractometer and NMR spectrometer.
Publisher Copyright:
© 2016 Elsevier B.V.
PY - 2016/4/1
Y1 - 2016/4/1
N2 - A series of keto-amine bidentate precursors 1–5, OCCH3CHCCH3NHR (where 1, R = C6H3-2,6-iPr2; 2, R = C6H2-2,4,6-Me3; 3, R = C6H4-2-tBu; 4, R = C6H4-2-OMe; 5, R = C6H4-2-OMe-5-Me) were synthesized and combined with [Ru(ɳ6-p-cymene)Cl2]2 to generate the monomeric arene-Ru derivatives, [Ru(ɳ6-p-cymene)(OCCH3CHCCH3NR)Cl] (where 6, R = C6H3-2,6-iPr2; 7, R = C6H2-2,4,6-Me3; 8, R = C6H4-2-tBu; 9, R = C6H4-2-OMe; 10, R = C6H4-2-OMe-5-Me) in moderate yield. The ruthenium derivatives effectively catalyzed the conversion rate in transfer hydrogenation of substituted acetophenone. The molecular structures of 2, 6–10 were determined by single crystal X-ray diffractometry in the solid state, revealing a four-coordination environment around the Ru atom. The potential anti-cancer activity of ruthenium derivatives against human hormone-refractory metastatic prostate cancer (HRMPC) cell lines was also studied.
AB - A series of keto-amine bidentate precursors 1–5, OCCH3CHCCH3NHR (where 1, R = C6H3-2,6-iPr2; 2, R = C6H2-2,4,6-Me3; 3, R = C6H4-2-tBu; 4, R = C6H4-2-OMe; 5, R = C6H4-2-OMe-5-Me) were synthesized and combined with [Ru(ɳ6-p-cymene)Cl2]2 to generate the monomeric arene-Ru derivatives, [Ru(ɳ6-p-cymene)(OCCH3CHCCH3NR)Cl] (where 6, R = C6H3-2,6-iPr2; 7, R = C6H2-2,4,6-Me3; 8, R = C6H4-2-tBu; 9, R = C6H4-2-OMe; 10, R = C6H4-2-OMe-5-Me) in moderate yield. The ruthenium derivatives effectively catalyzed the conversion rate in transfer hydrogenation of substituted acetophenone. The molecular structures of 2, 6–10 were determined by single crystal X-ray diffractometry in the solid state, revealing a four-coordination environment around the Ru atom. The potential anti-cancer activity of ruthenium derivatives against human hormone-refractory metastatic prostate cancer (HRMPC) cell lines was also studied.
KW - Hormone-refractory prostate cancer
KW - Keto-amine
KW - Ruthenium
KW - Transfer hydrogenation
UR - http://www.scopus.com/inward/record.url?scp=85029621145&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029621145&partnerID=8YFLogxK
U2 - 10.1016/j.jorganchem.2016.01.029
DO - 10.1016/j.jorganchem.2016.01.029
M3 - Article
AN - SCOPUS:85029621145
SN - 0022-328X
VL - 807
SP - 22
EP - 28
JO - Journal of Organometallic Chemistry
JF - Journal of Organometallic Chemistry
ER -